Zhejiang Jingjia Medical Technology Co., Ltd. specializes in the field of medical sodium hyaluronate gels, and products involve surgical anti-adhesion, ophthalmic viscoelastic, joint lubrication minimally invasive plastic filling, etc. The company attaches great importance to the research and development of new technologies and new products. Since established in 1995, we have been committed to the research and development of sodium hyaluronate technology and products, including the preparation of sodium hyaluronate raw materials. Through the efforts of the company’s older generation of researchers, we have successfully developed injection-grade raw materials for extracting sodium hyaluronate from cockscomb and applied to anti-adhesion after surgery, ophthalmic viscoelastic, joint injection, etc. The technology has the characteristics of a definite curative effect, stable quality, and low adverse reaction rate, then we have become one of the earliest domestic manufacturers to develop medical sodium hyaluronate.

To increase scientific research and improve technological innovation capabilities, Zhejiang Jingjia formally established a medical sodium hyaluronate cross-linking technology research and development center in November 2014, speeding up the investment in research and development funds, the purchase of equipment and the introduction of research and development talents. Deep-rooted and meticulous work, with great concentration, in June 2016, the R & D center was awarded the Hangzhou “Medical Sodium Hyaluronate Cross-linking Timely R & D Center” In November 2018, it was awarded the Zhejiang Province “Sodium Hyaluronate Crosslinking Technology Provincial High-tech Enterprise Research and Development Center”, which provides a solid guarantee for improving the company’s product development and technological innovation capabilities.